Final analysis results from TITAN: A phase III study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT). Meeting Abstract

Industry Collaboration International Collaboration

author list

  • Chi, Kim N.; Chowdhury, Simon; Bjartell, Anders; Chung, Byung Ha; de Santana Gomes, Andrea Juliana Pereira; Given, Robert; Soto, Alvaro Juarez; Merseburger, Axel Stuart; Ozguroglu, Mustafa; Uemura, Hirotsugu; Ye Dingwei; Triantos, Spyros; Mundle, Suneel; McCarthy, Sharon Anne; Larsen, Julie S.; Sun Weili; Bevans, Katherine; Zhang Ke; Bandyopadhyay, Nibedita; Agarwal, Neeraj; TITAN Investigators

publication date

  • February 20, 2021


published in



  • 39


  • 6